Despite a respectable return on capital, Coles Group's flat performance over five years signals a mature business in a holding pattern, leading investors to question its long-term compounding potential.
Entrepreneur Jesse Itzler's journey to selling Zico Coconut Water to Coca-Cola involved more than just a business plan. A pivotal moment came when he leveraged a casual connection with actor Matt Damon into a viral stunt that captured the beverage giant's imagination and ultimately closed the deal.
All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
Medical device giant Boston Scientific (BSX) is scheduled to release its fourth-quarter financial results before market open on Wednesday, with Wall Street anticipating continued strong revenue growth and another potential earnings beat.
Across India's villages and small towns, a new generation of workers is logging on after sunset to label the data that trains the world's most advanced AI systems. This quiet workforce, many of them women and first-generation graduates, is finding economic opportunity while reshaping global tech's supply chain.
All eyes are on Flex (NASDAQ: FLEX) as it prepares to release its fourth-quarter earnings before the market opens on Wednesday. The contract manufacturing leader has consistently outperformed Wall Street's revenue expectations, but can it do so again in a challenging macro environment?
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
Marius Borg Høiby, the son of Norway's Crown Princess Mette-Marit, is set to stand trial on Tuesday, facing a litany of charges including rape, domestic violence, and drug possession. The case marks a profound crisis for the modern Norwegian monarchy, unfolding against a backdrop of other royal controversies and health concerns.
A Los Angeles family is mourning the devastating loss of Regan Cole-Graham, 36, and her unborn daughter after a cycling accident. The mother of two was riding with her family when she was struck by a vehicle.
A sophisticated, high-conviction options trade by a large investor signals strong confidence in Edwards Lifesciences' fundamentals, with a potential breakout eyed for early 2026 tied to regulatory milestones and sustained growth in its mitral valve business.
Amid a challenging home furnishings market, luxury retailer RH is posting resilient results and gaining ground on competitors. A closer look reveals a strategy pivoting on international expansion, high-margin experiential offerings, and disciplined inventory management, setting the stage for ambitious long-term growth.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
Amid market volatility, a detailed analysis circulating among value investors makes a case for Kimberly-Clark Corporation. The thesis highlights the household products maker's resilient business model, technical support levels, and a valuation disconnect that could signal a compelling entry point for long-term portfolios.
With its trust fund projected to be depleted by 2032, the Social Security program faces a pivotal moment. Congress must enact reforms within the next seven years to prevent automatic, across-the-board benefit reductions for millions of Americans.
Newly obtained emails reveal former Border Patrol operations chief Gregory Bovino resisted calls for more targeted enforcement months before agents under his command were involved in two deadly shootings in Minneapolis, exposing internal divisions within DHS.
After a significant rebound, ACADIA Pharmaceuticals (ACAD) shares present a conundrum for investors. While a discounted cash flow model suggests deep undervaluation, the stock's volatile history and mixed performance metrics demand a closer look at the underlying narrative.
Gold prices staged a significant recovery on Tuesday, regaining some ground after a historic two-day sell-off. The focus now shifts to Chinese retail investors, whose appetite for bargain-hunting ahead of the Lunar New Year could be pivotal for the market's near-term direction.
Singapore Airlines (SGX:C6L) is demonstrating a disciplined approach to capital allocation, with a notable uptick in its return on capital employed (ROCE). While its current 6.3% return lags behind the broader airline industry average, the trend signals a potential turning point for the carrier as it seeks to solidify its post-pandemic recovery and build sustainable long-term value for shareholders.
